These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Eradication by immunization with mycobacterial vaccines and tumor cells of microscopic metastases remaining after surgery. Zbar B, Canti G, Ashley MP, Rapp HJ, Hunter JT, Ribi E. Cancer Res; 1979 May; 39(5):1597-603. PubMed ID: 427799 [No Abstract] [Full Text] [Related]
26. Eradication of microscopic hepatic metastases by active specific immunization. Sukumar S, Hunter JT, Terata N, Rapp HJ. Cancer Immunol Immunother; 1983 May; 14(3):151-4. PubMed ID: 6340824 [Abstract] [Full Text] [Related]
27. Histologic and ultrastructural studies of tumor regression in inbred guinea pigs after intralesional injection of Mycobacterium bovis (BCG). Hanna MG, Snodgrass MJ, Zbar B, Rapp HJ. Natl Cancer Inst Monogr; 1973 Dec; 39():71-85. PubMed ID: 4362524 [No Abstract] [Full Text] [Related]
28. Immunotherapy with nonviable microbial components. Ribi E, Milner KC, Granger DL, Kelly MT, Yamamoto K, Brehmer W, Parker R, Smith RF, Strain SM. Ann N Y Acad Sci; 1976 Dec; 277(00):228-38. PubMed ID: 187099 [Abstract] [Full Text] [Related]
29. An experimental model for immunotherapy of cancer. Zbar B, Ribi E, Rapp HJ. Natl Cancer Inst Monogr; 1973 Dec; 39():3-9. PubMed ID: 4595326 [No Abstract] [Full Text] [Related]
30. Activation of guinea pig macrophages by cell walls of Mycobacterium bovis, strain BCG. Kelly MT. Cell Immunol; 1976 Oct; 26(2):254-63. PubMed ID: 824056 [No Abstract] [Full Text] [Related]
31. Adjuvant-antigen requirements for active specific immunotherapy of microscopic metastases remaining after surgery. Ashley MP, Zbar B, Hunter JT, Rapp HJ, Sugimoto T. Cancer Res; 1980 Nov; 40(11):4197-203. PubMed ID: 7471060 [Abstract] [Full Text] [Related]
32. Regression of established oral tumors after intralesional injection of living BCG or BCG cell walls. Zbar B, Canti G, Rapp HJ, Bier J, Borsos T. Cancer; 1979 Apr; 43(4):1304-7. PubMed ID: 376088 [Abstract] [Full Text] [Related]
33. Effect of systemic administration of BCG cell walls on bronchogenic carcinoma in hamsters. Zwilling BS, Springer ST, Kaufman DG. J Natl Cancer Inst; 1977 May; 58(5):1473-7. PubMed ID: 323508 [Abstract] [Full Text] [Related]
34. Immunotherapy of metastatic cancer in guinea pigs: failure of intralesional BCG to influence the results of radical surgery. Hunter JT, Okuda T, Rapp HJ. J Natl Cancer Inst; 1977 Nov; 59(5):1435-9. PubMed ID: 909107 [Abstract] [Full Text] [Related]
35. Adjuvants for a tumor-specific vaccine: Bordetella pertussis or mycobacterial cell walls attached to oil droplets. Bartlett GL, Zbar B. J Natl Cancer Inst; 1973 May; 50(5):1385-90. PubMed ID: 4351399 [No Abstract] [Full Text] [Related]
36. [Immunotherapy of cancer with BCG]. Yamamura Y, Azuma I. Nihon Rinsho; 1974 Mar; 32(3):542-53. PubMed ID: 4603604 [No Abstract] [Full Text] [Related]
38. Postoperative active-specific immunotherapy of lymph node micrometastasis in a guinea pig tumor model. Bier H, Armonat G, Bier J, Schirrmacher V, Ganzer U. ORL J Otorhinolaryngol Relat Spec; 1989 Mar; 51(4):197-205. PubMed ID: 2664632 [Abstract] [Full Text] [Related]
39. Immunotherapy of cancer: regression of intradermal tumors and prevention of growth of lymph node metastases after intralesional injection of living Mycobacterium bovis. Zbar B, Bernstein ID, Bartlett GL, Hanna MG, Rapp HJ. J Natl Cancer Inst; 1972 Jul; 49(1):119-30. PubMed ID: 4338767 [No Abstract] [Full Text] [Related]
40. Immunological adjuvants in cancer immunotherapy. Baldwin RW. Dev Biol Stand; 1972 Jul; 38():3-12. PubMed ID: 344097 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]